Loxapax 25mg Capsule contains Loxapine, a dibenzoxazepine antipsychotic agent primarily used in the management of schizophrenia and other psychotic disorders. Loxapine exerts its therapeutic effects by antagonizing dopamine D2 receptors and modulating serotonergic pathways, thereby helping to restore the chemical balance in the brain and reduce psychotic symptoms such as hallucinations, delusions, and thought disorders. The 25mg dosage is typically prescribed based on the severity of symptoms and patient response, with careful titration to minimize adverse effects. Loxapax is indicated for both acute and maintenance treatment of schizophrenia, providing symptomatic relief and improving overall functional outcomes. Common side effects may include sedation, dry mouth, dizziness, and extrapyramidal symptoms, necessitating regular monitoring during therapy. Caution is advised in patients with a history of cardiovascular disease, seizures, or hepatic impairment. Loxapax should be used under strict medical supervision, with adherence to prescribed dosing schedules to optimize efficacy and safety. It is contraindicated in individuals with known hypersensitivity to Loxapine or related compounds. Patient education on potential side effects and the importance of compliance enhances therapeutic success and reduces the risk of relapse.